This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koumans, E. H.
Right arrow Articles by Papp, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koumans, E. H.
Right arrow Articles by Papp, J. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2003, p. 1507-1511, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1507-1511.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Comparison of Methods for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Using Commercially Available Nucleic Acid Amplification Tests and a Liquid Pap Smear Medium

Emilia H. Koumans,1,2* Carolyn M. Black,1 Lauri E. Markowitz,1 ElizabethR. Unger,1 Antonya Pierce,1,3 Mary K. Sawyer,2 and John R. Papp1

Centers for Disease Control and Prevention,1 Department of Pediatrics, Emory University, Atlanta, Georgia,2 Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee3

Received 6 August 2002/ Returned for modification 14 December 2002/ Accepted 28 December 2002

Annual screening for Chlamydia trachomatis infection is currently recommended for sexually active women 15 to 25 years old and for women older than 25 if they have a new or multiple sex partners and have not used condoms during the previous 3 months. Annual screening for cervical abnormalities using the Pap smear has achieved a substantial reduction in morbidity and mortality from cervical cancer. Screening for Neisseria gonorrhoeae infection has likely contributed significantly to the reduction in the rates of gonococcal infection. The introduction of liquid Pap smear methods using exfoliated cervical cells presents an opportunity to screen for these three conditions using one specimen. We evaluated the preservation of C. trachomatis and Neisseria gonorrhoeae DNAs from ThinPrep liquid media (PreservCyt; Cytyc Corp., Boxborough, Mass.); tested the feasibility of using a clinical specimen of this medium for the detection of cytologic abnormalities, C. trachomatis, and N. gonorrhoeae; evaluated the agreement between ligase chain reaction (LCR) performed on PreservCyt and LCR performed on a cervical specimen; and compared the performance of LCR performed on PreservCyt to those of LCR performed on a cervical specimen, culture, PCR performed on a cervical specimen, on urine, and on a vaginal specimen (a multiple-site infection status standard), and transcription-mediated amplification (for C. trachomatis only) from 255 sexually active adolescent women. The agreement between LCR performed on PreservCyt and LCR from a cervical swab in LCx transport medium was high (for C. trachomatis, agreement = 0.97 and kappa = 0.92; for N. gonorrhoeae, agreement = 0.99 and kappa = 0.96). Test performances were similar for LCR-urine, LCR-cervix, and LCR-ThinPrep, with sensitivities from 93 to 99% for C. trachomatis and 81 to 83% for N. gonorrhoeae and specificities from 95.5 to 99% for C. trachomatis and 99.1 to 99.6% for N. gonorrhoeae using a PCR-based multiple-site infection status standard. This is the first study to examine the agreement between liquid cytologic media and multiple nucleic acid amplification tests for the detection of C. trachomatis and N. gonorrhoeae from patient samples. Cytologic fluid shows promise for simultaneous screening for cytologic abnormalities and sexually transmitted infections.


* Corresponding author. Mailing address: DSTD/NCHSTP, 1600 Clifton Rd. NE, MS E-02, Atlanta, GA 30329. Phone: (404) 639-1897. Fax: (404) 639-8610. E-mail: exk0{at}cdc.gov.


Journal of Clinical Microbiology, April 2003, p. 1507-1511, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1507-1511.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Mossong, J, Muller, M, Majery, N, Mardaga, C, Decruyenaere, F, Schneider, F (2009). Screening for Chlamydia trachomatis in secondary schools, family planning and occupational health centres in Luxembourg. Sex. Transm. Infect. 85: 455-458 [Abstract] [Full Text]  
  • Bandea, C. I., Koumans, E. H., Sawyer, M. K., Dover, J., O'Connor, A., Papp, J. R., Unger, E. R., Braxton, J., Black, C. M. (2009). Evaluation of the Rapid BioStar Optical Immunoassay for Detection of Chlamydia trachomatis in Adolescent Women. J. Clin. Microbiol. 47: 215-216 [Abstract] [Full Text]  
  • Sevestre, H., Mention, J., Lefebvre, J.-F., Eb, F., Hamdad, F. (2009). Assessment of Chlamydia trachomatis infection by Cobas Amplicor PCR and in-house LightCycler assays using PreservCyt and 2-SP media in voluntary legal abortions. J Med Microbiol 58: 59-64 [Abstract] [Full Text]  
  • Chernesky, M., Jang, D., Portillo, E., Chong, S., Smieja, M., Luinstra, K., Petrich, A., MacRitchie, C., Ewert, R., Hayhoe, B., Sarabia, A., Thompson, F. (2007). Abilities of APTIMA, AMPLICOR, and ProbeTec Assays To Detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-Based Pap Samples. J. Clin. Microbiol. 45: 2355-2358 [Abstract] [Full Text]  
  • Chernesky, M., Freund, G. G., Hook, E. III, Leone, P., D'Ascoli, P., Martens, M. (2007). Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in North American Women by Testing SurePath Liquid-Based Pap Specimens in APTIMA Assays. J. Clin. Microbiol. 45: 2434-2438 [Abstract] [Full Text]  
  • Hjelmevoll, S. O., Olsen, M. E., Sollid, J. U. E., Haaheim, H., Unemo, M., Skogen, V. (2006). A Fast Real-Time Polymerase Chain Reaction Method for Sensitive and Specific Detection of the Neisseria gonorrhoeae porA Pseudogene. J. Mol. Diagn. 8: 574-581 [Abstract] [Full Text]  
  • Holland, J, Roberts, J (2005). Chlamydia trachomatis PCR positivity and inflammatory changes on cervical cytology. Sex. Transm. Infect. 81: 360-361 [Full Text]